Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
Asthma, Asthma in Children
About this trial
This is an interventional treatment trial for Asthma focused on measuring asthma, hospitalization, children
Eligibility Criteria
Inclusion Criteria: speak English or Spanish are at least 18 years old live in the District of Columbia, Maryland, or Virginia (DMV) have a child aged 4-12 years who is hospitalized due to asthma exacerbation. Exclusion Criteria: . Children ages 4-12 years with chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder . Children ages 4-12 years involved in interventions with behavioral component and/or novel asthma therapeutics will be excluded given overlap with the current intervention . Children ages 4-12 years in foster care . Families not residing in the DMV . Caregivers who do not speak English or Spanish
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Standard of Care
Hospital to Home Transition (H2H)
Control arm will receive the standard of care (SOC) after hospital discharge.
The intervention for this study is a multi-component navigation-supported intervention for children hospitalized with asthma. Navigators will work with families for 12-months post-discharge. Trained asthma educator/navigators will work to address challenges with asthma care after discharge; will include maximum 15 contacts/12 months. The asthma navigators within this study will attempt to maintain direct contact with participants primary care doctors through email, fax, and/or postal mail as means for delivering asthma action plans, prescription updates, and patient appointment scheduling. The asthma navigators for intervention participants will attempt to maintain contact with the school nurse in efforts to have a line of communication with the school. Asthma navigators will assist families in all home-based needs pertaining to their child's asthma.